Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04617522
Title Study to Determine an Appropriate Starting Dose of Sacituzumab Govitecan-hziy in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Pacific Shores Medical Group SUSPENDED Long Beach California 90813 United States Details
Christiana Care Health Services RECRUITING Newark Delaware 19713 United States Details
University of Maryland RECRUITING Baltimore Maryland 21201 United States Details
NEXT Austin WITHDRAWN Austin Texas 78758 United States Details
Oncology Consultants, P.A. RECRUITING Houston Texas 77030 United States Details
The University of Texas M.D. Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
Institut Bergonie Medical Oncology RECRUITING Bordeaux 33000 France Details
Centre Leon Berard RECRUITING Lyon 69373 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field